文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肺部微生物组:进展与前景。

The lung microbiome: progress and promise.

出版信息

J Clin Invest. 2021 Aug 2;131(15). doi: 10.1172/JCI150473.


DOI:10.1172/JCI150473
PMID:34338230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8321564/
Abstract

The healthy lung was long thought of as sterile, but recent advances using molecular sequencing approaches have detected bacteria at low levels. Healthy lung bacteria largely reflect communities present in the upper respiratory tract that enter the lung via microaspiration, which is balanced by mechanical and immune clearance and likely involves limited local replication. The nature and dynamics of the lung microbiome, therefore, differ from those of ecological niches with robust self-sustaining microbial communities. Aberrant populations (dysbiosis) have been demonstrated in many pulmonary diseases not traditionally considered microbial in origin, and potential pathways of microbe-host crosstalk are emerging. The question now is whether and how dysbiotic microbiota contribute to initiation or perpetuation of injury. The fungal microbiome and virome are less well studied. This Review highlights features of the lung microbiome, unique considerations in studying it, examples of dysbiosis in selected disease, emerging concepts in lung microbiome-host interactions, and critical areas for investigation.

摘要

长期以来,人们一直认为健康的肺部是无菌的,但最近使用分子测序方法的进展已经检测到低水平的细菌。健康肺部的细菌在很大程度上反映了存在于上呼吸道中的群落,它们通过微吸入进入肺部,微吸入通过机械和免疫清除来平衡,并且可能涉及有限的局部复制。因此,肺部微生物组的性质和动态与具有强大自我维持微生物群落的生态位不同。在许多传统上不被认为起源于微生物的肺部疾病中已经证明存在异常菌群(生态失调),并且微生物-宿主相互作用的潜在途径正在出现。现在的问题是,失调的微生物组是否以及如何导致损伤的发生或持续。真菌微生物组和病毒组的研究则较少。这篇综述强调了肺部微生物组的特征、研究肺部微生物组时的独特考虑因素、特定疾病中生态失调的实例、肺部微生物组-宿主相互作用中的新兴概念以及需要研究的关键领域。

相似文献

[1]
The lung microbiome: progress and promise.

J Clin Invest. 2021-8-2

[2]
The lung mycobiome: an emerging field of the human respiratory microbiome.

Front Microbiol. 2015-2-13

[3]
Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD.

Int J Mol Sci. 2020-4-11

[4]
The lung microbiome in lung transplantation.

J Heart Lung Transplant. 2021-8

[5]
The Human Respiratory Microbiome: Implications and Impact.

Semin Respir Crit Care Med. 2018-3-26

[6]
Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease.

J Med Virol. 2024-7

[7]
Characterizations of the Gut Bacteriome, Mycobiome, and Virome in Patients with Osteoarthritis.

Microbiol Spectr. 2023-2-14

[8]
Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens.

Curr Med Chem. 2020

[9]
Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis.

Front Endocrinol (Lausanne). 2022

[10]
The Human Respiratory Microbiome: Current Understandings and Future Directions.

Am J Respir Cell Mol Biol. 2023-3

引用本文的文献

[1]
Stacking ensemble learning models diagnose pulmonary infections using host transcriptome data from metatranscriptomics.

Sci Rep. 2025-8-20

[2]
Lung Acetate Levels Decline in Correlation With Increased Type 2 Allergic Markers in a House Dust Mite Allergic Mouse Model.

Clin Transl Allergy. 2025-8

[3]
The Lung Microbiome and Its Impact on Obstructive Sleep Apnea: A Diagnostic Frontier.

Diagnostics (Basel). 2025-6-4

[4]
Periodontitis aggravates pulmonary fibrosis by -promoted infiltration of neutrophils and Th17 cells.

Front Cell Infect Microbiol. 2025-5-27

[5]
ITIH4 alleviates OVA-induced asthma by regulating lung-gut microbiota.

Mol Med. 2025-5-23

[6]
Investigation of dynamic microbial migration patterns in the respiratory tract.

Front Cell Infect Microbiol. 2025-4-22

[7]
Lung Microenvironment Among Patients with Nontuberculous Mycobacterial Pulmonary Disease by Metagenomic Sequencing Technique.

Biomedicines. 2025-3-28

[8]
The Respiratory Tract Microbiome and Human Health.

Microb Biotechnol. 2025-5

[9]
The Microbiota-Human Health Axis.

Microorganisms. 2025-4-20

[10]
The impact of environmental factors on respiratory tract microbiome and respiratory system diseases.

Eur J Med Res. 2025-4-4

本文引用的文献

[1]
Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures.

Sci Rep. 2021-2-17

[2]
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.

NPJ Biofilms Microbiomes. 2021-2-5

[3]
The effect of taxonomic classification by full-length 16S rRNA sequencing with a synthetic long-read technology.

Sci Rep. 2021-1-18

[4]
Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.

Lancet Respir Med. 2021-6

[5]
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.

Cochrane Database Syst Rev. 2021-1-15

[6]
Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism.

Eur Respir J. 2021-7

[7]
Cancer Statistics, 2021.

CA Cancer J Clin. 2021-1

[8]
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.

Am J Respir Crit Care Med. 2021-6-15

[9]
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.

JAMA. 2020-12-8

[10]
Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.

Thorax. 2021-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索